CEACAM8 and COVID-19: Eosinophils from COVID-19 had decreased expression of the markers of the eosinophil lineage (CD15, CD66b, and CD193) (39) and higher expression of classical activation markers, such as CD62L, CD69, and CD147 (Fig. 4B and SI Appendix, Fig. S4A).